Kiniksa Pharmaceuticals International (KNSA) EBT Margin (2021 - 2026)
Kiniksa Pharmaceuticals International (KNSA) reported EBT Margin of 12.79% for Q2 2026, down 1.80 percentage points from 14.59% a year earlier and down 2.47 percentage points from the prior quarter.
Kiniksa Pharmaceuticals International (KNSA) EBT Margin (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Kiniksa Pharmaceuticals International's EBT Margin came in at 13.59%, up 10.89 percentage points year-over-year; for FY2025, it was 13.12%, up 21.66 percentage points from FY2024.
- EBT Margin has a four-year change of +419.25 percentage points (FY2021 to FY2025).
- By year, EBT Margin came in at -8.54% in FY2024 (-2.38 pp), -6.16% in FY2023 (-11.17 pp), 5.01% in FY2022 (+411.14 pp) and -406.13% in FY2021.
- Five-year quarterly EBT Margin spans a low of -253.51% in Q3 2021 and a high of 47.14% in Q3 2022.
- Year over year, EBT Margin gained in six of the last eight quarters, with an average year-over-year change of +10.01 percentage points.
- The high point for year-over-year EBT Margin in five years was Q2 2022 (a gain of 454.91 percentage points); the low point was Q3 2023 (a drop of 59.82 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 15.25% (Q1 2026), 11.51% (Q4 2025) and 15.02% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Kiniksa Pharmaceuticals International | 11.87 Bn | 10.61 Bn | 220.03 Mn | 12.79% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.79% |
| Mar 31, 2026 | 15.25% |
| Dec 31, 2025 | 11.51% |
| Sep 30, 2025 | 15.02% |
| Jun 30, 2025 | 14.59% |
| Mar 31, 2025 | 11.30% |
| Dec 31, 2024 | -13.86% |
| Sep 30, 2024 | -6.42% |
| Jun 30, 2024 | 2.12% |
| Mar 31, 2024 | -17.88% |
| Dec 31, 2023 | 2.94% |
| Sep 30, 2023 | -12.68% |
| Jun 30, 2023 | -1.73% |
| Mar 31, 2023 | -19.37% |
| Dec 31, 2022 | 11.05% |
| Sep 30, 2022 | 47.14% |
| Jun 30, 2022 | -71.43% |
| Mar 31, 2022 | -72.34% |
| Dec 31, 2021 | -192.34% |
| Sep 30, 2021 | -253.51% |
Kiniksa Pharmaceuticals International EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();